PDS Biotechnology
Cara Lalley is an experienced clinical trial management professional with a background in clinical research and administration. Currently serving as a Clinical Trial Manager at PDS Biotechnology, Cara has also held positions as a Senior Clinical Research Associate and Clinical Research Associate within the organization since January 2019. Previously, Cara worked as a Clinical Trial Assistant at Edge Therapeutics, Inc., supporting clinical teams and managing documentation in accordance with regulatory standards from September 2017 to January 2019. Cara's earlier experience includes serving as an Office Administrator at the New Jersey Institute for Disabilities, where administrative organization and client documentation were key responsibilities, and as a Quality Assurance Technician at Priority Medical, focusing on equipment quality and patient interaction. Cara holds a Bachelor of Science degree in Health Services from Monmouth University, earned in 2014.
This person is not in any offices
PDS Biotechnology
PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers;PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers.PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.